Tag Dr. Reddy’s launches drug-free migraine management

Hyderabad India; April 11, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a global pharmaceutical company, announced the

Continue ReadingDr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India